Registration Number
0206U004847,
0103U000295
, R & D reports
Title
Coagulologic, immunologic and clinical characteristics of lupus anticoagulant and determination of its role in development of resistance to substitution therapy for hemophilic patients.
popup.stage_title
Head
Loginsky V.E.,
Registration Date
24-03-2006
Organization
LVIV RESEARCH INSTITUTE OF BLOOD PATHOLOGY AND TRANSFUSIONAL MEDICINE
popup.description2
Character, specificity, clinical consequences, features of resistance to substitution therapy, caused by occurrence of immune inhibitor and Antiphospholipid Antibodies (APLA) in hemophilic patients were studied. Criteria of laboratory diagnostics of LA in patients with primary disorder of internal mechanism of thrombinogenesis, caused by factor VIII activity deficit; as well as criteria of differentiation from neutralizing inhibitor were developed.
Product Description
popup.authors
popup.nrat_date
2020-04-02